ATP1A3 and Global developmental delay: QotM #6 focused on the identification of candidate therapies for a case study of five patients with various mutations in ATP1A3 and asked specifically: “Given a mutation in gene ATP1A3 and a case description of associated phenotypes, can Translator propose new therapies?” The goal was to consider the phenotypes common to each case study, including motor symptoms, developmental delays, dystonia, and occasionally seizures, and use Translator to suggest candidate therapies.